Two case reports: EML4-ALK rearrangement large cell neuroendocrine carcinoma and literature review

Anaplastic lymphoma kinase gene (ALK) rearrangement is present in only approximately 5% of non-small cell lung cancers (NSCLCs) and is scarce in LCNEC patients. The conventional first-line treatment options are chemotherapy combined with immunotherapy or chemotherapy followed by palliative radiother...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qin, Zhang, Jingjing, Wang, Xuan, Zong, Wenkang, Sun, Leina, Qin, Jianwen, Yin, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646488/
https://www.ncbi.nlm.nih.gov/pubmed/38023218
http://dx.doi.org/10.3389/fonc.2023.1227980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10646488/
https://www.ncbi.nlm.nih.gov/pubmed/38023218
http://dx.doi.org/10.3389/fonc.2023.1227980

Ejemplares similares